Security Snapshot

Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) Institutional Ownership

CUSIP: 87918A105

13F Institutional Holders and Ownership History from Q2 2015 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

342

Shares (Excl. Options)

151,962,652

Price

$8.48

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+10,105,556
Value change
+$92,345,398
Number of holders
342
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
180,514,440
SEC-reported price per share
$6.58
Insider filing price
$6.58
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • TDOC - Teladoc Health, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 87918A105.
  • 342 institutions reported positions in Q2 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 321 to 342 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $775,742,263 to $1,288,234,012.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 342 institutions filings for Q2 2026.

Open SEC evidence

Security key

87918A105

Latest holder period

Q2 2026

13F holders

342

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
TDOC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.8% $99,368,053 13,556,351 BlackRock, Inc. 31 Mar 2025
VANGUARD PORTFOLIO MANAGEMENT LLC 7% $67,859,400 12,451,266 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $50,168,918 9,205,306 Vanguard Capital Management 31 Mar 2026
Voss Capital, LP 5% $58,486,679 9,025,722 Voss Capital, LP 17 Jun 2026
Point72 Asset Management, L.P. 3.3% -34% $44,796,726 -$23,430,960 5,795,178 -34% Point72 Asset Management, L.P. 30 Sep 2025

As of 30 Jun 2026, 342 institutional investors reported holding 151,962,652 shares of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC). This represents 84% of the company’s total 180,514,440 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
67%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 9% 16,223,134 +11% 0% $137,572,176
VANGUARD PORTFOLIO MANAGEMENT LLC 7% 12,685,592 +3.2% 0% $107,573,820
Point72 Asset Management, L.P. 4.6% 8,239,927 +6.7% 0.11% $69,874,581
RENAISSANCE TECHNOLOGIES LLC 4.5% 8,072,842 -0.16% 0.09% $68,457,700
Voss Capital, LP 4.5% 8,046,679 +92% 3.4% $68,235,838
VANGUARD CAPITAL MANAGEMENT LLC 4.4% 7,955,032 +1.2% 0% $67,458,671
DIMENSIONAL FUND ADVISORS LP 4.1% 7,371,699 +17% 0.01% $62,515,646
STATE STREET CORP 2.7% 4,962,382 +14% 0% $42,080,999
AMERICAN CENTURY COMPANIES INC 2.7% 4,894,504 +42% 0.02% $41,505,394
Allianz Asset Management GmbH 2.6% 4,666,596 -2.6% 0.04% $39,572,734
GEODE CAPITAL MANAGEMENT, LLC 2.6% 4,653,834 +11% 0% $39,472,353
GOLDMAN SACHS GROUP INC 2.1% 3,822,284 +41% 0% $32,412,969
Monaco Asset Management SAM 1.8% 3,167,979 -21% 10% $26,864,462
JUPITER ASSET MANAGEMENT LTD 1.7% 3,109,714 0% 0.13% $26,370,375
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.7% 3,063,252 +0.83% 0% $25,976,377
Quantinno Capital Management LP 1.6% 2,818,917 +7.5% 0.03% $23,904,416
FEDERATED HERMES, INC. 1.2% 2,127,008 +25% 0.03% $18,037,027
UBS Group AG 1.1% 2,052,026 +19% 0% $17,401,181
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.1% 2,040,051 0.01% $17,299,632
AMERIPRISE FINANCIAL INC 1.1% 2,004,550 +10% 0% $16,998,584
Pale Fire Capital SE 1.1% 1,973,762 -42% 1.2% $16,737,502
ACADIAN ASSET MANAGEMENT LLC 0.98% 1,775,668 +509% 0.02% $15,043,000
NORTHERN TRUST CORP 0.98% 1,775,398 -1.4% 0% $15,055,374
AQR CAPITAL MANAGEMENT LLC 0.97% 1,751,878 +71% 0.01% $14,855,924
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.74% 1,338,291 +17% 0.2% $11,348,708

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
45
Latest
Q2 2026
Rows shown
1-25 of 45
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 151,962,652 $1,288,234,012 +$92,345,398 $8.48 342
2026 Q1 142,267,280 $775,742,263 +$44,782,839 $5.45 321
2025 Q4 132,196,126 $925,457,856 +$47,124,945 $7.00 339
2025 Q3 123,376,453 $953,989,710 -$44,391,699 $7.73 349
2025 Q2 127,657,050 $1,111,810,150 +$28,908,039 $8.71 348
2025 Q1 124,764,453 $993,137,558 -$13,210,237 $7.96 368
2024 Q4 126,600,183 $1,150,909,215 +$5,732,507 $9.09 366
2024 Q3 125,343,265 $1,150,235,748 -$100,725,771 $9.18 352
2024 Q2 138,653,865 $1,356,107,775 +$78,896,049 $9.78 389
2024 Q1 129,813,184 $1,959,292,768 +$8,558,227 $15.10 411
2023 Q4 128,213,716 $2,762,470,436 +$64,064,682 $21.55 425
2023 Q3 124,707,305 $2,318,095,592 -$112,449,287 $18.59 418
2023 Q2 128,734,634 $3,259,624,540 -$197,804,335 $25.32 418
2023 Q1 136,344,301 $3,528,176,976 +$69,660,076 $25.90 416
2022 Q4 134,795,560 $3,187,915,143 -$88,463,415 $23.65 419
2022 Q3 137,929,338 $3,500,590,930 -$132,587,746 $25.35 421
2022 Q2 142,508,101 $4,752,897,156 -$35,457,280 $33.21 492
2022 Q1 135,294,586 $9,760,150,727 -$44,236,110 $72.13 640
2021 Q4 135,661,577 $12,464,617,010 -$96,730,604 $91.82 689
2021 Q3 133,460,521 $16,925,944,366 +$674,213,489 $126.81 738
2021 Q2 127,751,069 $21,259,926,344 +$1,036,756,412 $166.29 807
2021 Q1 121,322,454 $22,048,095,012 +$973,044,719 $181.75 873
2020 Q4 109,175,126 $21,828,607,477 +$6,575,258,095 $199.96 869
2020 Q3 75,563,046 $16,555,972,646 +$917,790,340 $219.24 730
2020 Q2 71,460,376 $13,644,498,539 -$180,652,715 $190.84 654
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .